In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2

Biochemistry

Volumn 51, Issue 29, 2012, Pages 5841-5850

  London, Nir ^a   Gullá, Stefano ^b   Keating, Amy E ^b   Schueler Furman, Ora ^a  

^a HEBREW UNIVERSITY   (Israel)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING POTENTIAL; BINDING SPECIFICITIES; BLIND PREDICTIONS; IN-SILICO; IN-VITRO; PEPTIDE BINDING; ROSETTA; SPOT ARRAYS; STRUCTURAL BASIS; STRUCTURAL MODELS; STRUCTURAL SIMILARITY; YEAST DISPLAY;

CELL DEATH; FORECASTING; MODEL STRUCTURES;

PEPTIDES;

BH3 PROTEIN; PROTEIN BCL 2; PROTEIN MCL 1;

ARTICLE; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; HUMANS; MEMBRANE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84864245944     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi3003567     Document Type: Article

References (71)

1. Youle, R. J. and Strasser, A. (2008) The BCL-2 protein family: opposing activities that mediate cell death Nat. Rev. Mol. Cell Biol. 9, 47-59
2. Adams, J. M. and Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival Science 281, 1322-1326 (Pubitemid 28406819)
3. Shamas-Din, A., Brahmbhatt, H., Leber, B., and Andrews, D. W. (2011) BH3-only proteins: Orchestrators of apoptosis Biochim. Biophys. Acta 1813, 508-520
4. Giam, M., Huang, D. C., and Bouillet, P. (2008) BH3-only proteins and their roles in programmed cell death Oncogene 27 (Suppl. 1) S128-136
5. Lomonosova, E. and Chinnadurai, G. (2008) BH3-only proteins in apoptosis and beyond: an overview Oncogene 27 (Suppl. 1) S2-19
6. Liu, X., Dai, S., Zhu, Y., Marrack, P., and Kappler, J. W. (2003) The structure of a Bcl-xL/Bim fragment complex: implications for Bim function Immunity 19, 341-352 (Pubitemid 37153411)
7. Petros, A. M., Olejniczak, E. T., and Fesik, S. W. (2004) Structural biology of the Bcl-2 family of proteins Biochim. Biophys. Acta 1644, 83-94 (Pubitemid 38281265)
8. Lama, D. and Sankararamakrishnan, R. (2010) Identification of core structural residues in the sequentially diverse and structurally homologous Bcl-2 family of proteins Biochemistry 49, 2574-2584
9. Fire, E., Gulla, S. V., Grant, R. A., and Keating, A. E. (2010) Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes Protein Sci. 19, 507-519
10. Letai, A. G. (2008) Diagnosing and exploiting cancer's addiction to blocks in apoptosis Nat. Rev. Cancer 8, 121-132 (Pubitemid 351161322)
11. Kang, M. H. and Reynolds, C. P. (2009) Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy Clin. Cancer Res. 15, 1126-1132
12. Mohammad, R., Giri, A., and Goustin, A. S. (2008) Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer Recent Pat Anticancer Drug Discov. 3, 20-30 (Pubitemid 351223207)
13. Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., Joseph, M. K., Kitada, S., Korsmeyer, S. J., Kunzer, A. R., Letai, A., Li, C., Mitten, M. J., Nettesheim, D. G., Ng, S., Nimmer, P. M., O'Connor, J. M., Oleksijew, A., Petros, A. M., Reed, J. C., Shen, W., Tahir, S. K., Thompson, C. B., Tomaselli, K. J., Wang, B., Wendt, M. D., Zhang, H., Fesik, S. W., and Rosenberg, S. H. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435, 677-681 (Pubitemid 40825512)
14. Nguyen, M., Marcellus, R. C., Roulston, A., Watson, M., Serfass, L., Murthy Madiraju, S. R., Goulet, D., Viallet, J., Belec, L., Billot, X., Acoca, S., Purisima, E., Wiegmans, A., Cluse, L., Johnstone, R. W., Beauparlant, P., and Shore, G. C. (2007) Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis Proc. Natl. Acad. Sci. U. S. A. 104, 19512-19517
15. Ku, B., Liang, C., Jung, J. U., and Oh, B. H. (2011) Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX Cell Res. 21, 627-641
16. Lee, E. F., Czabotar, P. E., Yang, H., Sleebs, B. E., Lessene, G., Colman, P. M., Smith, B. J., and Fairlie, W. D. (2009) Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands J. Biol. Chem. 284, 30508-30517
17. Lee, E. F., Czabotar, P. E., Smith, B. J., Deshayes, K., Zobel, K., Colman, P. M., and Fairlie, W. D. (2007) Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family Cell Death Differ. 14, 1711-1713 (Pubitemid 47278856)
18. Boersma, M. D., Sadowsky, J. D., Tomita, Y. A., and Gellman, S. H. (2008) Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: application to the Bim BH3 domain Protein Sci. 17, 1232-1240 (Pubitemid 351930920)
19. Lee, E. F., Czabotar, P. E., van Delft, M. F., Michalak, E. M., Boyle, M. J., Willis, S. N., Puthalakath, H., Bouillet, P., Colman, P. M., Huang, D. C., and Fairlie, W. D. (2008) A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation J. Cell Biol. 180, 341-355 (Pubitemid 351185920)
20. Day, C. L., Smits, C., Fan, F. C., Lee, E. F., Fairlie, W. D., and Hinds, M. G. (2008) Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1 J. Mol. Biol. 380, 958-971
21. Dutta, S., Gulla, S., Chen, T. S., Fire, E., Grant, R. A., and Keating, A. E. (2010) Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL J. Mol. Biol. 398, 747-762
22. Debartolo, J., Dutta, S., Reich, L., and Keating, A. E. (2012) Predictive Bcl-2 Family Binding Models Rooted in Experiment or Structure J. Mol. Biol. 10.1016/j.jmb.2012.05.022
23. Lee, E. F., Fedorova, A., Zobel, K., Boyle, M. J., Yang, H., Perugini, M. A., Colman, P. M., Huang, D. C., Deshayes, K., and Fairlie, W. D. (2009) Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins J. Biol. Chem. 284, 31315-31326
24. Kalyoncu, S., Keskin, O., and Gursoy, A. (2010) Interaction prediction and classification of PDZ domains BMC Bioinf. 11, 357
25. Ferraro, E., Via, A., Ausiello, G., and Helmer-Citterich, M. (2005) A neural strategy for the inference of SH3 domain-peptide interaction specificity BMC Bioinf. 6 (Suppl. 4) S13
26. Obenauer, J. C. and Yaffe, M. B. (2004) Computational prediction of protein-protein interactions Methods Mol. Biol. 261, 445-468
27. Liao, W. W. and Arthur, J. W. (2011) Predicting peptide binding to major histocompatibility complex molecules Autoimmun. Rev. 10, 469-473
28. Kaufmann, K., Shen, N., Mizoue, L., and Meiler, J. (2011) A physical model for PDZ-domain/peptide interactions J. Mol. Model. 17, 315-324
29. Hou, T., Xu, Z., Zhang, W., McLaughlin, W. A., Case, D. A., Xu, Y., and Wang, W. (2009) Characterization of domain-peptide interaction interface: a generic structure-based model to decipher the binding specificity of SH3 domains Mol. Cell. Proteomics 8, 639-649
30. Chaudhury, S. and Gray, J. J. (2009) Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance Structure 17, 1636-1648
31. Grigoryan, G. and Keating, A. E. (2006) Structure-based prediction of bZIP partnering specificity J. Mol. Biol. 355, 1125-1142 (Pubitemid 43012152)
32. Apgar, J. R., Hahn, S., Grigoryan, G., and Keating, A. E. (2009) Cluster expansion models for flexible-backbone protein energetics J. Comput. Chem. 30, 2402-2413
33. Smith, C. A. and Kortemme, T. (2010) Structure-based prediction of the peptide sequence space recognized by natural and synthetic PDZ domains J. Mol. Biol. 402, 460-474
34. King, C. A. and Bradley, P. (2010) Structure-based prediction of protein-peptide specificity in Rosetta Proteins 78, 3437-3449
35. London, N., Lamphear, C., Houghland, J., Fierke, C., and Schueler-Furman, O. (2011) Identification of a novel class of Farnesylation targets by structure-based modeling of binding specificity PLoS Comput. Biol. 7, e1002170
36. Fu, X., Apgar, J. R., and Keating, A. E. (2007) Modeling backbone flexibility to achieve sequence diversity: the design of novel alpha-helical ligands for Bcl-xL J. Mol. Biol. 371, 1099-1117 (Pubitemid 47101807)
37. Mandell, D. J. and Kortemme, T. (2009) Backbone flexibility in computational protein design Curr. Opin. Biotechnol. 20, 420-428
38. London, N., Movshovitz-Attias, D., and Schueler-Furman, O. (2010) The structural basis of peptide-protein binding strategies Structure 18, 188-199
39. Vanhee, P., Reumers, J., Stricher, F., Baeten, L., Serrano, L., Schymkowitz, J., and Rousseau, F. (2010) PepX: a structural database of non-redundant protein-peptide complexes Nucleic Acids Res. 38, D545-551
40. Vanhee, P., Stricher, F., Baeten, L., Verschueren, E., Lenaerts, T., Serrano, L., Rousseau, F., and Schymkowitz, J. (2009) Protein-peptide interactions adopt the same structural motifs as monomeric protein folds Structure 17, 1128-1136
41. Stein, A., Ceol, A., and Aloy, P. (2011) 3did: identification and classification of domain-based interactions of known three-dimensional structure Nucleic Acids Res. 39, D718-723
42. Stein, A. and Aloy, P. (2008) Contextual specificity in peptide-mediated protein interactions PLoS One 3, e2524
43. Raveh, B., London, N., and Schueler-Furman, O. (2010) Sub-angstrom modeling of complexes between flexible peptides and globular proteins Proteins 78, 2029-2040
44. Raveh, B., London, N., Zimmerman, L., and Schueler-Furman, O. (2011) Rosetta FlexPepDock ab-initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their Receptors PLoS One 6, e18934
45. London, N., Raveh, B., Cohen, E., Fathi, G., and Schueler-Furman, O. (2011) Rosetta FlexPepDock web server - high resolution modeling of peptide-protein interactions Nucleic Acids Res. 39, W249-W253
46. Antes, I. (2010) DynaDock: A new molecular dynamics-based algorithm for protein-peptide docking including receptor flexibility Proteins 78, 1084-1104
47. Niv, M. Y. and Weinstein, H. (2005) A flexible docking procedure for the exploration of peptide binding selectivity to known structures and homology models of PDZ domains J. Am. Chem. Soc. 127, 14072-14079 (Pubitemid 41437055)
48. Arun Prasad, P. and Gautham, N. (2008) A new peptide docking strategy using a mean field technique with mutually orthogonal Latin square sampling J. Comput.-Aided Mol. Des. 22, 815-829
49. Schon, O., Friedler, A., Bycroft, M., Freund, S. M., and Fersht, A. R. (2002) Molecular mechanism of the interaction between MDM2 and p53 J. Mol. Biol. 323, 491-501 (Pubitemid 35283675)
50. Grigoryan, G., Reinke, A. W., and Keating, A. E. (2009) Design of protein-interaction specificity gives selective bZIP-binding peptides Nature 458, 859-864
51. Jochim, A. L. and Arora, P. S. (2009) Assessment of helical interfaces in protein-protein interactions Mol. Biosyst. 5, 924-926
52. London, N., Raveh, B., Movshovitz-Attias, D., and Schueler-Furman, O. (2010) Can self-inhibitory peptides be derived from the interfaces of globular protein-protein interactions? Proteins 78, 3140-3149
53. Henchey, L. K., Jochim, A. L., and Arora, P. S. (2008) Contemporary strategies for the stabilization of peptides in the alpha-helical conformation Curr. Opin. Chem. Biol. 12, 692-697
54. Stewart, M. L., Fire, E., Keating, A. E., and Walensky, L. D. (2010) The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer Nat. Chem. Biol. 6, 595-601
55. Schreiber, G. and Keating, A. E. (2011) Protein binding specificity versus promiscuity Curr. Opin. Struct. Biol. 21, 50-61
56. Hilpert, K., Winkler, D. F., and Hancock, R. E. (2007) Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion Nat. Protoc. 2, 1333-1349 (Pubitemid 46952315)
57. Lazaridis, T. and Karplus, M. (1999) Effective energy function for proteins in solution Proteins 35, 133-152 (Pubitemid 29165128)
58. Yanover, C. and Bradley, P. (2011) Extensive protein and DNA backbone sampling improves structure-based specificity prediction for C2H2 zinc fingers Nucleic Acids Res. 39, 4564-4576
59. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E. (2000) The Protein Data Bank Nucleic Acids Res. 28, 235-242 (Pubitemid 30047768)
60. Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., and Huang, D. C. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function Mol. Cell 17, 393-403 (Pubitemid 40193310)
61. Rautureau, G. J., Day, C. L., and Hinds, M. G. (2010) Intrinsically disordered proteins in bcl-2 regulated apoptosis Int. J. Mol. Sci. 11, 1808-1824
62. Petros, A. M., Nettesheim, D. G., Wang, Y., Olejniczak, E. T., Meadows, R. P., Mack, J., Swift, K., Matayoshi, E. D., Zhang, H., Thompson, C. B., and Fesik, S. W. (2000) Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies Protein Sci. 9, 2528-2534 (Pubitemid 32105735)
63. Munoz, V. and Serrano, L. (1995) Elucidating the folding problem of helical peptides using empirical parameters. II. Helix macrodipole effects and rational modification of the helical content of natural peptides J. Mol. Biol. 245, 275-296
64. Warr, M. R., Acoca, S., Liu, Z., Germain, M., Watson, M., Blanchette, M., Wing, S. S., and Shore, G. C. (2005) BH3-ligand regulates access of MCL-1 to its E3 ligase FEBS Lett. 579, 5603-5608 (Pubitemid 41455637)
65. Lee, D. H., Ha, J. H., Kim, Y., Bae, K. H., Park, J. Y., Choi, W. S., Yoon, H. S., Park, S. G., Park, B. C., Yi, G. S., and Chi, S. W. (2011) Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy Biochem. Biophys. Res. Commun. 408, 541-547
66. Kim, N., Yoo, J. C., Han, J. Y., Hwang, E. M., Kim, Y. S., Jeong, E. Y., Sun, C. H., Yi, G. S., Roh, G. S., Kim, H. J., Kang, S. S., Cho, G. J., Park, J. Y., and Choi, W. S. (2012) Human nuclear clusterin mediates apoptosis by interacting with Bcl-XL through C-terminal coiled coil domain J. Cell. Physiol. 227, 1157-1167
67. Kvansakul, M., Wei, A. H., Fletcher, J. I., Willis, S. N., Chen, L., Roberts, A. W., Huang, D. C., and Colman, P. M. (2010) Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1 PLoS Pathog. 6, e1001236
68. Flanagan, A. M. and Letai, A. (2008) BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2 Cell Death Differ. 15, 580-588 (Pubitemid 351267308)
69. Banadyga, L., Lam, S. C., Okamoto, T., Kvansakul, M., Huang, D. C., and Barry, M. (2011) Deerpox virus encodes an inhibitor of apoptosis that regulates Bak and Bax J. Virol. 85, 1922-1934
70. Pena, J. C., Thompson, C. B., Recant, W., Vokes, E. E., and Rudin, C. M. (1999) Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck Cancer 85, 164-170 (Pubitemid 29031371)
71. van Delft, M. F. and Huang, D. C. (2006) How the Bcl-2 family of proteins interact to regulate apoptosis Cell Res. 16, 203-213 (Pubitemid 43247978)